Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma.

Advances in Hematology
Adam PetrichSamir Parekh

Abstract

Burkitt lymphoma (BL) is a very aggressive subtype of non-Hodgkin's lymphoma that occurs with higher frequency in patients with HIV/AIDS. Patients with HIV-related BL (HIV-BL) are usually treated with high-intensity, multi-agent chemotherapy regimens. The addition of the monoclonal antibody Rituximab to chemotherapy has also been studied in this setting. The potential risks and benefits of commonly used regimens are reviewed herein, along with a discussion of controversial issues in the practical management of HIV-BL, including concurrent anti-retroviral therapy, treatment of relapsed and/or refractory disease, and the role of stem cell transplantation.

References

Feb 1, 1976·Cancer·F K Nkrumah, I V Perkins
Jun 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M L McMasterJ D Hainsworth
Apr 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T M LopezJ Johnson
Aug 26, 1971·British Medical Journal·J L Ziegler, A Z Bluming
Sep 15, 1980·International Journal of Cancer. Journal International Du Cancer·C L OlwenyJ L Ziegler
Mar 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I MagrathI D Horak
Nov 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A SparanoJ P Dutcher
Aug 1, 1996·Nature Biotechnology
Nov 18, 2000·Journal of the National Cancer Institute·UNKNOWN International Collaboration on HIV and Cancer
Apr 20, 2002·European Journal of Clinical Nutrition·A S Truswell
Oct 24, 2002·Blood·Lydie Da CostaNarla Mohandas
Jan 11, 2003·Clinical Lymphoma·Alexandra M Levine
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gail Gazelle
Jan 1, 1990·Biotechnology Advances·J Spizek
Sep 2, 2004·Nature Biotechnology·F Raymond Salemme
Sep 29, 2006·Antimicrobial Agents and Chemotherapy·Adrian S RayGerry R Rhodes
Jul 22, 2009·Current Opinion in Oncology·Ian Magrath
Sep 1, 2009·Clinical Lymphoma & Myeloma·Jennifer L KellyJonathan W Friedberg
Sep 5, 2009·Clinical Medicine : Journal of the Royal College of Physicians of London·Jane Dacre, Susan Shepherd
Aug 5, 2010·Current Opinion in Oncology·Ariela Noy
Jan 26, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey M PeppercornUNKNOWN American Society of Clinical Oncology

❮ Previous
Next ❯

Citations

Sep 18, 2015·Cancer Medicine·Vidya VedhamSomdat Mahabir
Mar 5, 2016·Surgical Pathology Clinics·Lawrence K Low, Joo Y Song
Dec 22, 2017·International Journal of STD & AIDS·Alina KhanNeil Nagovski
May 2, 2020·International Journal of Molecular Sciences·Maria Manuel AzevedoFátima Baltazar
Aug 11, 2020·Journal of Cancer Research and Clinical Oncology·Leonardo Alves de Souza RiosShaheen Mowla

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.